SOURCE: Xtalks

Xtalks Webinars

September 11, 2015 08:17 ET

Phenotypic Screening -- Complex and Disease-Relevant Human Primary Cell Assays, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - September 11, 2015) - Join featured speaker David Fischer, Senior Director of Biology, and Site Head of Charles River in Leiden, the Netherlands, for a one-hour session on Tuesday, September 15, 2015 at 11am EDT (4pm BST/ GMT +1).

In the past few years, there has been a revival of phenotypic screening for hit discovery and profiling. It is generally accepted that overexpression of targets in heterologous systems has a risk of creating functional artefacts, and in principle, such an assay is single-target focused. As the understanding of the complex interplay of networks and pathways within cellular processes increases, the need for ways to screen compounds in the correct disease context also grows. As practitioners are starting to appreciate polypharmacology and can also harness the knowledge gained from clinical genetics using human primary cells from patients, drug discovery research and high-throughput screening is going through the next paradigm shift.

To learn more about this event visit: Phenotypic Screening -- Complex and Disease-Relevant Human Primary Cell Assays

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

Image Available:

Contact Information